Chemoinformaics analysis of 3,4-di-O-caffeoylquinic acid
| Molecular Weight | 516.455 | nRot | 7 |
| Heavy Atom Molecular Weight | 492.263 | nRig | 23 |
| Exact Molecular Weight | 516.127 | nRing | 3 |
| Solubility: LogS | -1.935 | nHRing | 0 |
| Solubility: LogP | 1.694 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 67.377 |
| nHD | 7 | BPOL | 30.153 |
| QED | 0.156 |
| Synth | 4.141 |
| Natural Product Likeliness | 1.642 |
| NR-PPAR-gamma | 0.335 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.934 |
| HIA | 0.602 |
| CACO-2 | -6.386 |
| MDCK | 0.0000104 |
| BBB | 0.093 |
| PPB | 0.983037 |
| VDSS | 0.429 |
| FU | 0.0232929 |
| CYP1A2-inh | 0.343 |
| CYP1A2-sub | 0.018 |
| CYP2c19-inh | 0.096 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.509 |
| CYP2c9-sub | 0.486 |
| CYP2d6-inh | 0.062 |
| CYP2d6-sub | 0.159 |
| CYP3a4-inh | 0.142 |
| CYP3a4-sub | 0.042 |
| CL | 4.014 |
| T12 | 0.929 |
| hERG | 0.09 |
| Ames | 0.066 |
| ROA | 0.129 |
| SkinSen | 0.923 |
| Carcinogencity | 0.148 |
| EI | 0.081 |
| Respiratory | 0.053 |
| NR-Aromatase | 0.848 |
| Antiviral | Yes |
| Prediction | 0.784746 |